• About Us
    • Fact Checking Policy
    • Ownership & funding information
    • Volunteer
  • Subscribe
  • Letter submission
    • Submissions Policy
  • Contact Us
The Online Citizen Asia
  • Opinion
    • Editorial
    • Commentaries
    • Letters
    • Comments
  • Current Affairs
    • Singapore
    • Malaysia
    • Indonesia
    • China
    • ASEAN
    • Asia
    • International
  • Finance
    • Economics
    • Labour
    • Property
    • Business
  • Community
    • Arts & Culture
    • Consumer Watch
    • NGO
    • Lifestyle
    • Travel
  • Politics
    • Civil Society
    • Parliament
    • Transport
    • Education
    • Environment
    • Health
    • Housing
  • Law & Order
    • Legislation
    • Court Cases
No Result
View All Result
  • Opinion
    • Editorial
    • Commentaries
    • Letters
    • Comments
  • Current Affairs
    • Singapore
    • Malaysia
    • Indonesia
    • China
    • ASEAN
    • Asia
    • International
  • Finance
    • Economics
    • Labour
    • Property
    • Business
  • Community
    • Arts & Culture
    • Consumer Watch
    • NGO
    • Lifestyle
    • Travel
  • Politics
    • Civil Society
    • Parliament
    • Transport
    • Education
    • Environment
    • Health
    • Housing
  • Law & Order
    • Legislation
    • Court Cases
No Result
View All Result
The Online Citizen Asia
No Result
View All Result

US authorizes J&J COVID vaccine for emergency use

by The Online Citizen
28/02/2021
in Health, International
Reading Time: 2 mins read
0
US authorizes J&J COVID vaccine for emergency use

A file photo taken on 17 November 2020 shows vials with COVID-19 Vaccine stickers attached and syringes with the logo of US pharmaceutical company Johnson & Johnson in London. The US Food and Drug Administration (FDA) on 27 February 2021 issued emergency use authorization for the Johnson & Johnson COVID-19 vaccine/AFP

The United States on Saturday authorized Johnson & Johnson’s COVID vaccine for emergency use, giving the nation a third shot to battle the outbreak that has killed more than 500,000 Americans.

The single-shot vaccine is highly effective in preventing severe COVID-19, including against newer variants, the Food and Drug Administration (FDA) said before giving it a greenlight.

“The authorization of this vaccine expands the availability of vaccines, the best medical prevention method for COVID-19, to help us in the fight against this pandemic, which has claimed over half a million lives in the United States,” said the US regulator’s acting director Janet Woodcock.

In large clinical trials, the J&J vaccine’s efficacy against severe disease was 85.9 percent in the United States, 81.7 percent in South Africa, and 87.6 percent in Brazil.

Overall, among 39,321 participants across all regions, the efficacy against severe COVID-19 was 85.4 percent, but it fell to 66.1 percent when including moderate forms of the disease.

Crucially, analyses of various demographic groups revealed no marked differences across age, race, or people with underlying conditions.

A third vaccine is seen as a vital means to ramp up the immunization rate in the United States, where more than 500,000 people have lost their lives to the coronavirus.

100 million doses by June

The J&J vaccine is the third to be greenlighted in the United States after Pfizer’s and Moderna’s were provisionally approved in December.

Over 65 million people in America have so far received at least one shot of either the Pfizer or Moderna vaccines — but unlike those, the J&J vaccine requires just one dose, and is stored at fridge temperatures, offering logistical and practical advantages.

The J&J shot is slightly less protective than Pfizer and Moderna’s two-shot regimens, which both have an efficacy of around 95 percent against all forms of COVID-19 from the classic coronavirus strain.

There was a hint, based on preliminary data, that the vaccine might be effective against asymptomatic infection — though J&J said it needs to do more research to confirm this.

The company has announced it aims to deliver a total of 20 million doses by the end of March, with 100 million by June — though the US is pushing to expedite that timeline.

The J&J vaccine uses a common-cold causing adenovirus, which has been genetically modified so that it can’t replicate, to carry the gene for a key protein of the coronavirus into human cells.

– AFP

For just US$7.50 a month, sign up as a subscriber on The Online Citizen Asia (and enjoy ads-free experience on our site) to support our mission to transform TOC into an alternative mainstream press.
Source: AFP
Tags: AFPCOVID-19J&JUS

Related Posts

US businesses ‘fear internet curbs in Hong Kong’
AFP

Hong Kong offers free flights after COVID isolation

02/02/2023
US tells vaccinated people in high COVID risk areas to mask again
AFP

White House says US COVID emergency status to end 11 May

31/01/2023
WHO panel in talks on COVID emergency status
AFP

WHO panel in talks on COVID emergency status

27/01/2023
Zero-COVID left in dust as Chinese revellers fuel travel boom
AFP

Zero-COVID left in dust as Chinese revellers fuel travel boom

19/01/2023
China ends quarantine for overseas travellers after years of self-imposed isolation
AFP

China back to ‘normal’ after end of COVID curbs: official

17/01/2023
UK health firm estimates 9,000 COVID deaths in China per day but Chinese govt says only 10 since 7 Dec
AFP

‘Not necessary’ to dwell on COVID death tally, Chinese experts say

11/01/2023
Subscribe
Connect withD
Login
I allow to create an account
When you login first time using a Social Login button, we collect your account public profile information shared by Social Login provider, based on your privacy settings. We also get your email address to automatically create an account for you in our website. Once your account is created, you'll be logged-in to this account.
DisagreeAgree
Notify of
Connect withD
I allow to create an account
When you login first time using a Social Login button, we collect your account public profile information shared by Social Login provider, based on your privacy settings. We also get your email address to automatically create an account for you in our website. Once your account is created, you'll be logged-in to this account.
DisagreeAgree
0 Comments
Inline Feedbacks
View all comments

Latest posts

A multi-party parliament is the only way to make sure that Singapore continues to not condone or tolerate corruption

03/02/2023
Anwar criticised over appointing own daughter as his senior advisor

Anwar criticised over appointing own daughter as his senior advisor

03/02/2023
Level of unemployment in Indonesia shows failure in the Job Creation Law, says KSPI

Level of unemployment in Indonesia shows failure in the Job Creation Law, says KSPI

02/02/2023

The Keppel bribery scandal tests Singapore’s zero-tolerance policy towards corruption

02/02/2023
Singapore Law Watch removes commentary on CPIB’s decision to not prosecute former Keppel executives

Singapore Law Watch removes commentary on CPIB’s decision to not prosecute former Keppel executives

02/02/2023
US businesses ‘fear internet curbs in Hong Kong’

Hong Kong offers free flights after COVID isolation

02/02/2023
Why is Gautam Adani’s Indian empire in turmoil?

Why is Gautam Adani’s Indian empire in turmoil?

02/02/2023
India’s Adani shares plunge again after stock sale cancelled

India’s Adani empire loses more than US$100 bn after fraud claims

02/02/2023

Trending posts

Former Singaporean shares change of life in Australia with annual pay of S$80,000 as a plumber

Former Singaporean shares change of life in Australia with annual pay of S$80,000 as a plumber

by Yee Loon
30/01/2023
25

...

Earning only S$400 a month, delivery-rider turned hawker threw in the towel after two years of running a rojak stall

Earning only S$400 a month, delivery-rider turned hawker threw in the towel after two years of running a rojak stall

by Yee Loon
26/01/2023
24

...

They have done a fine job of confusing us about the jobs situation

They have done a fine job of confusing us about the jobs situation

by Augustine Low
01/02/2023
33

...

Two Indian nationals paid about S$330 and S$730 respectively for forged certificates submitted in their S-Pass application

MOM found issuing EPs meant for foreign PMETs to PRC waitress and general worker

by Correspondent
26/01/2023
41

...

Singapore warns slower economic growth in 2023

Less than 1 in 10 jobs created in first three quarters of 2022 went to Singaporeans?

by Leong Szehian
28/01/2023
69

...

Excessively charging for an essential need, and calling it affordable because people still can pay for it?

by Terry Xu
31/01/2023
39

...

February 2021
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
« Jan   Mar »

The Online Citizen is a regional online publication based in Taiwan and formerly Singapore’s longest-running independent online media platform.

Navigation

  • Editorial
  • Commentaries
  • Opinion
  • Politics
  • Community

Support

  • Contact Us
  • Letter submission
  • Membership subscription

Follow Us

  • Facebook
  • Twitter
  • YouTube
  • Instagram
  • Fact Checking Policy
  • Privacy Policy

© 2022 - 2023 The Online Citizen Asia

No Result
View All Result
  • Opinion
    • Editorial
    • Commentaries
    • Comments
  • Current Affairs
    • Malaysia
    • Indonesia
    • China
    • ASEAN
    • Asia
    • International
  • Finance
    • Economics
    • Labour
    • Property
    • Business
  • Community
    • Civil Society
    • Arts & Culture
    • Consumer Watch
    • NGO
  • Politics
    • Parliament
    • Transport
    • Education
    • Environment
    • Health
    • Housing
  • Law & Order
    • Legislation
    • Court Cases
  • Lifestyle
    • Travel
  • Subscribers login

© 2022 - 2023 The Online Citizen Asia

wpDiscuz